Cancer Research Cancer Research Funding Available  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 3677-3681, July 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrews, P. A.
Right arrow Articles by Albright, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrews, P. A.
Right arrow Articles by Albright, K. D.

Role of the Na+,K+-Adenosine Triphosphatase in the Accumulation of cis-Diamminedichloroplatinum(II) in Human Ovarian Carcinoma Cells1

Paul A. Andrews2, Stephen C. Mann3, Hung H. Huynh and Kathleen D. Albright

Cancer Center and Department of Medicine, University of California, San Diego, La Jolla, California 92093

We examined the importance of the Na+,K+-ATPase in cisplatin (DDP) accumulation in 2008 human ovarian carcinoma cells and describe changes in the Na+,K+-ATPase in DDP-resistant cells with DDP accumulation defects. Approximately 50% of DDP accumulation was inhibitable by ouabain. DDP accumulation into 2008 cells could be maximally inhibited when cells were preincubated with ouabain for 1 h prior to DDP exposure. The half-maximal inhibition was obtained with 0.13 µM ouabain. Similar inhibition of DDP accumulation was obtained when the Na+,K+-ATPase was blocked by ATP depletion or by incubating cells in K+-free medium. This same percentage of DDP accumulation was Na+ dependent and varied directly with Na+ concentration. These effects on DDP accumulation could be detected as early as 1 min after the imposition of 0-trans conditions, strongly suggesting that the inhibition was due to modulation of a drug influx step. The Na+,K+-ATPase in 2008/DDP cells had a similar KD for ouabain binding and 36% less Na+,K+-ATPase molecules/mg of protein than 2008 cells. 2008/DDP cells were 2.3 ± 0.2 (SE, n = 3) fold cross-resistant to ouabain in a continuous exposure clonogenic assay. Despite these changes in the Na+,K+-ATPase, the net basal Na+,K+-ATPase activity was the same in sensitive and DDP-resistant cells as determined by ouabain-inhibitable 86Rb+ influx. The basal Na+ levels were also similar in the sensitive and resistant cells. These data suggest that DDP accumulation is partially Na+ dependent and that, therefore, the Na+,K+-ATPase which maintains the Na+ gradient may play an important role in determining how much DDP enters cells. Whether there is a causal link between the changes in the Na+,K+-ATPase in DDP-resistant cells and their DDP accumulation defect is not yet known.

1 Supported by Grant CA-23100 from the National Cancer Institute, Grant CH-417 from the American Cancer Society, and Grant 100-R107 from Bristol-Myers, Co. This work was conducted in part by the Clayton Foundation for Research, California Division. P. A. A. is a Clayton Foundation Investigator.

2 To whom requests for reprints should be addressed, at Georgetown University, 4 Research Court, Rockville, MD 20850.

3 Clayton Foundation Fellow.

Received 10/25/90. Accepted 5/ 6/91.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
L.-S. Wang, K.-C. Chow, Y.-C. Lien, K.-T. Kuo, and W.-Y. Li
Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma
Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 419 - 424.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Katano, R. Safaei, G. Samimi, A. Holzer, M. Tomioka, M. Goodman, and S. B. Howell
Confocal Microscopic Analysis of the Interaction between Cisplatin and the Copper Transporter ATP7B in Human Ovarian Carcinoma Cells
Clin. Cancer Res., July 1, 2004; 10(13): 4578 - 4588.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Samimi, N. M. Varki, S. Wilczynski, R. Safaei, D. S. Alberts, and S. B. Howell
Increase in Expression of the Copper Transporter ATP7A during Platinum Drug-Based Treatment Is Associated with Poor Survival in Ovarian Cancer Patients
Clin. Cancer Res., December 1, 2003; 9(16): 5853 - 5859.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Katano, A. Kondo, R. Safaei, A. Holzer, G. Samimi, M. Mishima, Y.-M. Kuo, M. Rochdi, and S. B. Howell
Acquisition of Resistance to Cisplatin Is Accompanied by Changes in the Cellular Pharmacology of Copper
Cancer Res., November 15, 2002; 62(22): 6559 - 6565.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. Lin, T. Okuda, A. Holzer, and S. B. Howell
The Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae
Mol. Pharmacol., November 1, 2002; 62(5): 1154 - 1159.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Brouillard, D. Tondelier, A. Edelman, and M. Baudouin-Legros
Drug Resistance Induced by Ouabain via the Stimulation of MDR1 Gene Expression in Human Carcinomatous Pulmonary Cells
Cancer Res., February 1, 2001; 61(4): 1693 - 1698.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.